Impact of baseline liver tumor burden on treatment outcomes with 177Lu-Dotatate in the Netter-1 study 2018 (English)In: European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, E-ISSN 1619-7089, Vol. 45, no Supplement 1, p. S60-S60Article in journal, Meeting abstract (Other academic) Published

Place, publisher, year, edition, pages

2018. Vol. 45, no Supplement 1, p. S60-S60

National Category

Radiology, Nuclear Medicine and Medical Imaging

Identifiers

URN: urn:nbn:se:uu:diva-373338DOI: 10.1007/s00259-018-4148-3ISI: 000449266200095OAI: oai:DiVA.org:uu-373338DiVA, id: diva2:1278790

Conference

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), OCT 13-17, 2018, Dusseldorf, GERMANY.

Note

Meeting Abstract: OP-180

Available from: 2019-01-15 Created: 2019-01-15 Last updated: 2019-01-15Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records BETA

Öberg, Kjell

Search in DiVA

By author/editor

Öberg, Kjell

By organisation

Endocrine Tumor Biology

In the same journal

European Journal of Nuclear Medicine and Molecular Imaging

On the subject

Radiology, Nuclear Medicine and Medical Imaging

Search outside of DiVA

GoogleGoogle ScholarTotal: 6 hits